{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:26:26Z","timestamp":1790663186106,"version":"4.1.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["metabolismjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.metabol.2021.154802","type":"journal-article","created":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T13:43:18Z","timestamp":1622727798000},"page":"154802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Molecular mechanisms underlying hepatitis C virus infection-related diabetes"],"prefix":"10.1016","volume":"121","author":[{"given":"Yujin","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangdi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0005","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4239\/wjd.v5.i5.586","article-title":"Hepatitis C virus infection and type 1 and type 2 diabetes mellitus [J]","volume":"5","author":"Antonelli","year":"2014","journal-title":"World J Diabetes"},{"key":"10.1016\/j.metabol.2021.154802_bb0010","doi-asserted-by":"crossref","first-page":"153952","DOI":"10.1016\/j.metabol.2019.153952","article-title":"Environmental and genetic contributions to diabetes [J]","volume":"100S","author":"Tremblay","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2021.154802_bb0015","series-title":"[J]. IDF diabetes Atlas","author":"International Diabetes Federation","year":"2017"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0020","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00125-018-4616-0","article-title":"Correction to: epidemiology of diabetes and diabetic complications in China [J]","volume":"61","author":"Ma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.metabol.2021.154802_bb0025","doi-asserted-by":"crossref","first-page":"154766","DOI":"10.1016\/j.metabol.2021.154766","article-title":"Insulin resistance, cardiovascular stiffening and cardiovascular disease [J]","volume":"119","author":"Hill","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2021.154802_bb0030","series-title":"New hepatitis data highlight need for urgent global response","year":"2018"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0035","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1128\/jvi.65.3.1105-1113.1991","article-title":"Structure and organization of the hepatitis C virus genome isolated from human carriers [J]","volume":"65","author":"Takamizawa","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.metabol.2021.154802_bb0040","first-page":"55","article-title":"Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties [J]","volume":"242","author":"Reed","year":"2000","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0045","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1038\/s41598-017-04206-6","article-title":"Hepatitis B and C virus infection and diabetes mellitus: a cohort study [J]","volume":"7","author":"Hong","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0050","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jiph.2011.05.004","article-title":"Hepatitis C virus infection in a population with high incidence of type 2 diabetes: impact on diabetes complications [J]","volume":"4","author":"Chehadeh","year":"2011","journal-title":"J Infect Public Health"},{"issue":"9","key":"10.1016\/j.metabol.2021.154802_bb0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.4254\/wjh.v6.i9.677","article-title":"Insulin resistance and steatosis in HBV-HCV co-infected patients: role of PNPLA3 polymorphisms and impact on liver fibrosis progression [J]","volume":"6","author":"Zampino","year":"2014","journal-title":"World J Hepatol"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0060","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/QAI.0000000000001443","article-title":"Active HCV replication but not HCV or CMV seropositive status is associated with incident and prevalent type 2 diabetes in persons living with HIV [J]","volume":"75","author":"De Luca","year":"2017","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0065","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study [J]","volume":"166","author":"Wang","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0070","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis [J]","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0075","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jare.2016.11.003","article-title":"Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: a review [J]","volume":"8","author":"Gastaldi","year":"2017","journal-title":"J Adv Res"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0080","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/CS20190900","article-title":"Chronic hepatitis C virus infection impairs insulin secretion by regulation of p38delta MAPK-dependent exocytosis in pancreatic beta-cells [J]","volume":"134","author":"Chen","year":"2020","journal-title":"Clin Sci (Lond)"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0085","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db16-0731","article-title":"Circulating microRNA-122 is associated with the risk of new-onset metabolic syndrome and type 2 diabetes [J]","volume":"66","author":"Willeit","year":"2017","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0090","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/jcmm.13553","article-title":"Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: a driver function of circulating miRNAs [J]","volume":"22","author":"Singhal","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0095","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/eri.09.3","article-title":"Hepatitis C and diabetes: the inevitable coincidence? [J]","volume":"7","author":"Lonardo","year":"2009","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"14","key":"10.1016\/j.metabol.2021.154802_bb0100","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.3748\/wjg.v18.i14.1642","article-title":"Relationship between hepatitis C virus infection and type 2 diabetes mellitus: meta-analysis [J]","volume":"18","author":"Naing","year":"2012","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.metabol.2021.154802_bb0105","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States [J]","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"issue":"12","key":"10.1016\/j.metabol.2021.154802_bb0110","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1111\/j.1572-0241.1998.00688.x","article-title":"HCV and diabetes mellitus: evidence for a negative association [J]","volume":"93","author":"Mangia","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0115","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/hep.27047","article-title":"Relationship of hepatitis C virus infection with diabetes in the U.S. population [J]","volume":"60","author":"Ruhl","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0120","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/hep.25867","article-title":"Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C [J]","volume":"56","author":"Aghemo","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cmi.2015.12.030","article-title":"Rapid decline of fasting glucose in HCV diabetic patients treated with direct-acting antiviral agents [J]","volume":"22","author":"Pavone","year":"2016","journal-title":"Clin Microbiol Infect"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0130","first-page":"1153","article-title":"Hepatitis C virus (HCV) treatment with directly acting agents reduces the risk of incident diabetes: results from electronically retrieved cohort of HCV infected veterans (ERCHIVES) [J]","volume":"70","author":"Butt","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0135","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM [J]","volume":"37","author":"Defronzo","year":"1988","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2007.04.002","article-title":"Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences [J]","volume":"47","author":"Leclercq","year":"2007","journal-title":"J Hepatol"},{"issue":"1\u20132","key":"10.1016\/j.metabol.2021.154802_bb0145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1006806722619","article-title":"The IRS-signalling system: a network of docking proteins that mediate insulin action [J]","volume":"182","author":"White","year":"1998","journal-title":"Mol Cell Biochem"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0150","first-page":"972","article-title":"Clinical review 125: the insulin receptor and its cellular targets [J]","volume":"86","author":"Kido","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"Pt 3","key":"10.1016\/j.metabol.2021.154802_bb0155","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/bj3460561","article-title":"The PI3K-PDK1 connection: more than just a road to PKB [J]","volume":"346","author":"Vanhaesebroeck","year":"2000","journal-title":"Biochem J"},{"issue":"50","key":"10.1016\/j.metabol.2021.154802_bb0160","doi-asserted-by":"crossref","first-page":"7391","DOI":"10.1038\/sj.onc.1209100","article-title":"AKT signaling in normal and malignant cells [J]","volume":"24","author":"Testa","year":"2005","journal-title":"Oncogene"},{"issue":"6865","key":"10.1016\/j.metabol.2021.154802_bb0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism [J]","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.metabol.2021.154802_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/nu10101366","article-title":"Chlorogenic acid targeting of the AKT PH domain activates AKT\/GSK3beta\/FOXO1 signaling and improves glucose metabolism [J]","volume":"10","author":"Gao","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.metabol.2021.154802_bb0175","doi-asserted-by":"crossref","first-page":"172657","DOI":"10.1016\/j.ejphar.2019.172657","article-title":"Liver and insulin resistance: new wine in old bottle!!! [J]","volume":"862","author":"Patel","year":"2019","journal-title":"Eur J Pharmacol"},{"issue":"7","key":"10.1016\/j.metabol.2021.154802_bb0180","doi-asserted-by":"crossref","first-page":"6048","DOI":"10.1128\/JVI.72.7.6048-6055.1998","article-title":"The native form and maturation process of hepatitis C virus core protein [J]","volume":"72","author":"Yasui","year":"1998","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1574-6968.2001.tb10796.x","article-title":"Hepatitis C virus core protein: intriguing properties and functional relevance [J]","volume":"202","author":"Ray","year":"2001","journal-title":"FEMS Microbiol Lett"},{"issue":"6502","key":"10.1016\/j.metabol.2021.154802_bb0190","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/372182a0","article-title":"Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1 [J]","volume":"372","author":"Tamemoto","year":"1994","journal-title":"Nature"},{"issue":"6670","key":"10.1016\/j.metabol.2021.154802_bb0195","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/36116","article-title":"Disruption of IRS-2 causes type 2 diabetes in mice [J]","volume":"391","author":"Withers","year":"1998","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.metabol.2021.154802_bb0200","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","article-title":"Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2 [J]","volume":"55","author":"Copps","year":"2012","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0205","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/JVI.01672-07","article-title":"Hepatitis C virus core protein upregulates serine phosphorylation of insulin receptor substrate-1 and impairs the downstream akt\/protein kinase B signaling pathway for insulin resistance [J]","volume":"82","author":"Banerjee","year":"2008","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0210","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.hep.2003.09.012","article-title":"Impaired IRS-1\/PI3-kinase signaling in patients with HCV: a mechanism for increased prevalence of type 2 diabetes [J]","volume":"38","author":"Aytug","year":"2003","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0215","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/hep.21703","article-title":"Insulin resistance and liver injury in hepatitis C is not associated with virus-specific changes in adipocytokines [J]","volume":"46","author":"Cua","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.metabol.2021.154802_bb0220","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/j.1572-0241.2003.08728.x","article-title":"Tumor necrosis factor-alpha-induced insulin resistance may mediate the hepatitis C virus-diabetes association [J]","volume":"98","author":"Knobler","year":"2003","journal-title":"Am J Gastroenterol"},{"issue":"Suppl. 3","key":"10.1016\/j.metabol.2021.154802_bb0225","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1365-2362.32.s3.4.x","article-title":"Identifying the links between obesity, insulin resistance and beta-cell function: potential role of adipocyte-derived cytokines in the pathogenesis of type 2 diabetes [J]","volume":"32","author":"Greenberg","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"19","key":"10.1016\/j.metabol.2021.154802_bb0230","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1128\/JVI.77.19.10237-10249.2003","article-title":"Proteasome activator PA28gamma-dependent nuclear retention and degradation of hepatitis C virus core protein [J]","volume":"77","author":"Moriishi","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0235","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1128\/JVI.01683-06","article-title":"Involvement of the PA28gamma-dependent pathway in insulin resistance induced by hepatitis C virus core protein [J]","volume":"81","author":"Miyamoto","year":"2007","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0240","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000282095","article-title":"PTEN in non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis and cancer [J]","volume":"28","author":"Peyrou","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/j.metabol.2021.154802_bb0245","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12985-015-0241-4","article-title":"Inhibition of IRS-1 by hepatitis C virus infection leads to insulin resistance in a PTEN-dependent manner [J]","volume":"12","author":"Gao","year":"2015","journal-title":"Virol J"},{"issue":"44","key":"10.1016\/j.metabol.2021.154802_bb0250","doi-asserted-by":"crossref","first-page":"16454","DOI":"10.1073\/pnas.0607626103","article-title":"Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates [J]","volume":"103","author":"Solinas","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0255","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2010.06.021","article-title":"Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C [J]","volume":"54","author":"Garcia-Monzon","year":"2011","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.metabol.2021.154802_bb0260","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1099\/jgv.0.000221","article-title":"HCV upregulates Bim through the ROS\/JNK signalling pathway, leading to Bax-mediated apoptosis [J]","volume":"96","author":"Deng","year":"2015","journal-title":"J Gen Virol"},{"issue":"9","key":"10.1016\/j.metabol.2021.154802_bb0265","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/107156021000006653","article-title":"Oxidative stress EPR measurement in human liver by radical-probe technique. Correlation with etiology, histology and cell proliferation [J]","volume":"36","author":"Valgimigli","year":"2002","journal-title":"Free Radic Res"},{"issue":"9","key":"10.1016\/j.metabol.2021.154802_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024957","article-title":"Hepatitis C virus proteins activate NRF2\/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells [J]","volume":"6","author":"Ivanov","year":"2011","journal-title":"PLoS One"},{"issue":"7086","key":"10.1016\/j.metabol.2021.154802_bb0275","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature04634","article-title":"Reactive oxygen species have a causal role in multiple forms of insulin resistance [J]","volume":"440","author":"Houstis","year":"2006","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0280","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.3390\/v7062745","article-title":"HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells [J]","volume":"7","author":"Ivanov","year":"2015","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0285","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.cell.2004.12.041","article-title":"Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases [J]","volume":"120","author":"Kamata","year":"2005","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0290","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.50.5.937","article-title":"Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression [J]","volume":"50","author":"Lochhead","year":"2001","journal-title":"Diabetes"},{"issue":"43","key":"10.1016\/j.metabol.2021.154802_bb0295","doi-asserted-by":"crossref","first-page":"12361","DOI":"10.3748\/wjg.v21.i43.12361","article-title":"Hepatitis C virus NS5A promotes insulin resistance through IRS-1 serine phosphorylation and increased gluconeogenesis [J]","volume":"21","author":"Parvaiz","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0300","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00705-013-1892-3","article-title":"Hepatitis C virus nonstructural protein 5A favors upregulation of gluconeogenic and lipogenic gene expression leading towards insulin resistance: a metabolic syndrome [J]","volume":"159","author":"Parvaiz","year":"2014","journal-title":"Arch Virol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0305","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2337\/diabetes.52.3.634","article-title":"Enhanced basal activation of mitogen-activated protein kinases in adipocytes from type 2 diabetes: potential role of p38 in the downregulation of GLUT4 expression [J]","volume":"52","author":"Carlson","year":"2003","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0310","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.1840380408","article-title":"Hepatitis C virus core protein activates ERK and p38 MAPK in cooperation with ethanol in transgenic mice [J]","volume":"38","author":"Tsutsumi","year":"2003","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.metabol.2021.154802_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133264","article-title":"HCV NS5A up-regulates COX-2 expression via IL-8-mediated activation of the ERK\/JNK MAPK pathway [J]","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0320","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yexcr.2004.12.024","article-title":"Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK\/ERK signaling pathway via cellular receptors [J]","volume":"305","author":"Zhao","year":"2005","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0325","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.biochi.2004.10.019","article-title":"Positive and negative regulation of insulin signaling through IRS-1 phosphorylation [J]","volume":"87","author":"Gual","year":"2005","journal-title":"Biochimie"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0330","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1365-2893.2011.01447.x","article-title":"Hepatitis C core protein impairs insulin downstream signalling and regulatory role of IGFBP-1 expression [J]","volume":"19","author":"Alberstein","year":"2012","journal-title":"J Viral Hepat"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0335","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1002\/hep.21634","article-title":"The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms [J]","volume":"45","author":"Pazienza","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0340","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1073\/pnas.96.5.2071","article-title":"The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation [J]","volume":"96","author":"Zhang","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0345","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)63408-6","article-title":"Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3 [J]","volume":"165","author":"Kawaguchi","year":"2004","journal-title":"Am J Pathol"},{"issue":"Pt 7","key":"10.1016\/j.metabol.2021.154802_bb0350","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1099\/vir.0.020644-0","article-title":"Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells [J]","volume":"91","author":"Pazienza","year":"2010","journal-title":"J Gen Virol"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0355","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1210\/mend.14.6.0446","article-title":"A rapamycin-sensitive pathway down-regulates insulin signaling via phosphorylation and proteasomal degradation of insulin receptor substrate-1 [J]","volume":"14","author":"Haruta","year":"2000","journal-title":"Mol Endocrinol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0360","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4161\/cbt.2.5.446","article-title":"Rhebbing up mTOR: new insights on TSC1 and TSC2, and the pathogenesis of tuberous sclerosis [J]","volume":"2","author":"Kwiatkowski","year":"2003","journal-title":"Cancer Biol Ther"},{"issue":"35","key":"10.1016\/j.metabol.2021.154802_bb0365","doi-asserted-by":"crossref","first-page":"14056","DOI":"10.1073\/pnas.0706517104","article-title":"Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance [J]","volume":"104","author":"Tremblay","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.metabol.2021.154802_bb0370","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1128\/JVI.00050-12","article-title":"Hepatitis C virus activates the mTOR\/S6K1 signaling pathway in inhibiting IRS-1 function for insulin resistance [J]","volume":"86","author":"Bose","year":"2012","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0375","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0014-5793(01)02242-6","article-title":"Protein kinase B (PKB\/Akt)--a key regulator of glucose transport? [J]","volume":"492","author":"Hajduch","year":"2001","journal-title":"FEBS Lett"},{"issue":"31","key":"10.1016\/j.metabol.2021.154802_bb0380","doi-asserted-by":"crossref","first-page":"20139","DOI":"10.1016\/S0021-9258(17)32138-5","article-title":"Comparison of heterotrimeric protein phosphatase 2A containing different B subunits [J]","volume":"269","author":"Kamibayashi","year":"1994","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.metabol.2021.154802_bb0385","doi-asserted-by":"crossref","first-page":"8617","DOI":"10.1074\/jbc.M211181200","article-title":"The formation and activity of PP2A holoenzymes do not depend on the isoform of the catalytic subunit [J]","volume":"278","author":"Zhou","year":"2003","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0390","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1128\/JVI.73.5.3718-3722.1999","article-title":"Activation of the grp78 and grp94 promoters by hepatitis C virus E2 envelope protein [J]","volume":"73","author":"Liberman","year":"1999","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.metabol.2021.154802_bb0395","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1096\/fj.04-3455fje","article-title":"Hepatitis C virus envelope proteins regulate CHOP via induction of the unfolded protein response [J]","volume":"19","author":"Chan","year":"2005","journal-title":"FASEB J"},{"issue":"31","key":"10.1016\/j.metabol.2021.154802_bb0400","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1038\/sj.onc.1208673","article-title":"Hepatitis C virus core triggers apoptosis in liver cells by inducing ER stress and ER calcium depletion [J]","volume":"24","author":"Benali-Furet","year":"2005","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0405","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/hep.21611","article-title":"Activation of endoplasmic reticulum stress response by hepatitis viruses up-regulates protein phosphatase 2A [J]","volume":"46","author":"Christen","year":"2007","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0410","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tim.2005.02.004","article-title":"Hepatitis C virus, ER stress, and oxidative stress [J]","volume":"13","author":"Tardif","year":"2005","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0415","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jhep.2008.04.007","article-title":"Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C [J]","volume":"49","author":"Bernsmeier","year":"2008","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.metabol.2021.154802_bb0420","doi-asserted-by":"crossref","first-page":"5936","DOI":"10.1128\/JVI.02344-09","article-title":"Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression [J]","volume":"84","author":"Banerjee","year":"2010","journal-title":"J Virol"},{"issue":"31","key":"10.1016\/j.metabol.2021.154802_bb0425","doi-asserted-by":"crossref","first-page":"12860","DOI":"10.1074\/jbc.M117.785030","article-title":"Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice [J]","volume":"292","author":"Lerat","year":"2017","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0430","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3 [J]","volume":"33","author":"Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0435","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/hep.26905","article-title":"Is genotype 3 of the hepatitis C virus the new villain? [J]","volume":"59","author":"Goossens","year":"2014","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.metabol.2021.154802_bb0440","doi-asserted-by":"crossref","first-page":"7089","DOI":"10.3748\/wjg.v20.i23.7089","article-title":"Pathogenesis and significance of hepatitis C virus steatosis: an update on survival strategy of a successful pathogen [J]","volume":"20","author":"Lonardo","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0445","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data [J]","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"issue":"44","key":"10.1016\/j.metabol.2021.154802_bb0450","doi-asserted-by":"crossref","first-page":"9674","DOI":"10.3748\/wjg.v22.i44.9674","article-title":"Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - evidence from three different disease models: NAFLD, HCV and HIV [J]","volume":"22","author":"Lonardo","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"1 Suppl","key":"10.1016\/j.metabol.2021.154802_bb0455","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.jhep.2014.08.003","article-title":"Facts and fictions of HCV and comorbidities: steatosis, diabetes mellitus, and cardiovascular diseases [J]","volume":"61","author":"Negro","year":"2014","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0460","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes [J]","volume":"59","author":"Birkenfeld","year":"2014","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.metabol.2021.154802_bb0465","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","article-title":"The heterogeneous pathogenesis of type 1 diabetes mellitus [J]","volume":"15","author":"Ilonen","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0470","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1002\/hep.510280531","article-title":"Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative-strand viral RNA in various tissues [J]","volume":"28","author":"Laskus","year":"1998","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0475","doi-asserted-by":"crossref","first-page":"940","DOI":"10.2337\/diacare.28.4.940","article-title":"Hepatitis C virus infection and human pancreatic beta-cell dysfunction [J]","volume":"28","author":"Masini","year":"2005","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0480","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s12985-017-0905-3","article-title":"A preliminary analysis of hepatitis C virus in pancreatic islet cells [J]","volume":"14","author":"Blackard","year":"2017","journal-title":"Virol J"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0485","article-title":"Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway [J]","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154802_bb0490","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0083-6729(08)00616-X","article-title":"Insulin granule biogenesis, trafficking and exocytosis [J]","volume":"80","author":"Hou","year":"2009","journal-title":"Vitam Horm"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0495","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2008.11.018","article-title":"Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis [J]","volume":"136","author":"Sumara","year":"2009","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0500","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2337\/dc05-2509","article-title":"Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: a case-control study [J]","volume":"29","author":"Lecube","year":"2006","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0505","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1053\/j.gastro.2009.11.050","article-title":"Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance [J]","volume":"138","author":"Milner","year":"2010","journal-title":"Gastroenterology"},{"issue":"12","key":"10.1016\/j.metabol.2021.154802_bb0510","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm1202-792","article-title":"Beta cells are responsible for CXCR3-mediated T-cell infiltration in insulitis [J]","volume":"8","author":"Frigerio","year":"2002","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0515","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/17425255.2020.1711884","article-title":"Clinical significance of chemokine receptor antagonists [J]","volume":"16","author":"Miao","year":"2020","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0520","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1749-6632.2009.04813.x","article-title":"CXCR3, inflammation, and autoimmune diseases [J]","volume":"117","author":"Lacotte","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0525","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cytogfr.2014.01.006","article-title":"CXCR3, CXCL10 and type 1 diabetes [J]","volume":"25","author":"Antonelli","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0530","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2249.2011.04538.x","article-title":"Serum titres of anti-glutamic acid decarboxylase-65 and anti-IA-2 autoantibodies are associated with different immunoregulatory milieu in newly diagnosed type 1 diabetes patients [J]","volume":"168","author":"Gabbay","year":"2012","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.metabol.2021.154802_bb0535","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.4049\/jimmunol.173.11.7017","article-title":"CXC chemokine ligand 10 neutralization suppresses the occurrence of diabetes in nonobese diabetic mice through enhanced beta cell proliferation without affecting insulitis [J]","volume":"173","author":"Morimoto","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.metabol.2021.154802_bb0540","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1507\/endocrj.K10E-076","article-title":"Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes [J]","volume":"57","author":"Uno","year":"2010","journal-title":"Endocr J"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0545","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2893.2001.00309.x","article-title":"Clinical significance of elevated serum interferon-inducible protein-10 levels in hepatitis C virus carriers with persistently normal serum transaminase levels [J]","volume":"8","author":"Itoh","year":"2001","journal-title":"J Viral Hepat"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0550","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2893.2005.00540.x","article-title":"Gene expression profile of T-cell-specific chemokines in human hepatocyte-derived cells: evidence for a synergistic inducer effect of cytokines and hepatitis C virus proteins [J]","volume":"12","author":"Apolinario","year":"2005","journal-title":"J Viral Hepat"},{"issue":"2\u20133","key":"10.1016\/j.metabol.2021.154802_bb0555","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12026-014-8569-1","article-title":"Cytokines and HCV-related autoimmune disorders [J]","volume":"60","author":"Antonelli","year":"2014","journal-title":"Immunol Res"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0560","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.autrev.2008.07.017","article-title":"Immunopathogenesis of HCV-related endocrine manifestations in chronic hepatitis and mixed cryoglobulinemia [J]","volume":"8","author":"Antonelli","year":"2008","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0565","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1672-0229(08)60044-3","article-title":"A brief review on the mechanisms of miRNA regulation [J]","volume":"7","author":"Cai","year":"2009","journal-title":"Genomics Proteomics Bioinformatics"},{"issue":"9","key":"10.1016\/j.metabol.2021.154802_bb0570","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrendo.2013.86","article-title":"Circulating microRNAs as novel biomarkers for diabetes mellitus [J]","volume":"9","author":"Guay","year":"2013","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0575","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virol.2009.11.036","article-title":"Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells [J]","volume":"398","author":"Liu","year":"2010","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0580","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting [J]","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0585","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/hep.27369","article-title":"Circulating microRNAs as a marker for liver injury in human immunodeficiency virus patients [J]","volume":"61","author":"Anadol","year":"2015","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0590","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116768","article-title":"Circulating miRNA-122 levels are associated with hepatic necroinflammation and portal hypertension in HIV\/HCV coinfection [J]","volume":"10","author":"Jansen","year":"2015","journal-title":"PLoS One"},{"issue":"5740","key":"10.1016\/j.metabol.2021.154802_bb0595","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1126\/science.1113329","article-title":"Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA [J]","volume":"309","author":"Jopling","year":"2005","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.metabol.2021.154802_bb0600","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2337\/db10-0699","article-title":"HLA class I and genetic susceptibility to type 1 diabetes: results from the type 1 diabetes genetics consortium [J]","volume":"59","author":"Noble","year":"2010","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0605","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA region in the prediction of type 1 diabetes [J]","volume":"11","author":"Noble","year":"2011","journal-title":"Curr Diab Rep"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0610","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/gutjnl-2013-306287","article-title":"Additive effects of HLA alleles and innate immune genes determine viral outcome in HCV infection [J]","volume":"64","author":"Fitzmaurice","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0615","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/hep.20261","article-title":"Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source [J]","volume":"40","author":"Mckiernan","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0620","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/321005","article-title":"Racial differences in HLA class II associations with hepatitis C virus outcomes [J]","volume":"184","author":"Thio","year":"2001","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0625","doi-asserted-by":"crossref","first-page":"235","DOI":"10.7326\/0003-4819-158-4-201302190-00003","article-title":"Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts [J]","volume":"158","author":"Duggal","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1016\/j.metabol.2021.154802_bb0630","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.jhep.2012.12.024","article-title":"A genome-wide association study of HCV-induced liver cirrhosis in the Japanese population identifies novel susceptibility loci at the MHC region [J]","volume":"58","author":"Urabe","year":"2013","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.metabol.2021.154802_bb0635","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3760\/cma.j.issn.0366-6999.20132988","article-title":"Extrahepatic manifestations of chronic hepatitis C virus infection: 297 cases from a tertiary medical center in Beijing, China [J]","volume":"127","author":"Cheng","year":"2014","journal-title":"Chin Med J (Engl)"},{"issue":"7","key":"10.1016\/j.metabol.2021.154802_bb0640","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.cgh.2018.11.059","article-title":"Significant increase in risk of fibrosis or cirrhosis at time of HCV diagnosis for Hispanics with diabetes and obesity compared with other ethnic groups [J]","volume":"17","author":"Turner","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.metabol.2021.154802_bb0645","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1007\/s10620-015-3760-3","article-title":"Concurrent obesity, diabetes, and steatosis increase risk of advanced fibrosis among HCV patients: a systematic review [J]","volume":"60","author":"Dyal","year":"2015","journal-title":"Dig Dis Sci"},{"issue":"12","key":"10.1016\/j.metabol.2021.154802_bb0650","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.metabol.2007.07.011","article-title":"Impact of diabetes mellitus on prognosis of patients infected with hepatitis C virus [J]","volume":"56","author":"Kita","year":"2007","journal-title":"Metabolism"},{"issue":"8","key":"10.1016\/j.metabol.2021.154802_bb0655","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.dld.2007.05.005","article-title":"HCV and diabetes. A two-question-based reappraisal [J]","volume":"39","author":"Lonardo","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10.1016\/j.metabol.2021.154802_bb0660","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cgh.2006.05.013","article-title":"Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis [J]","volume":"4","author":"N\u2019kontchou","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0665","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/j.gastro.2003.01.001","article-title":"Hepatitis C: a metabolic liver disease [J]","volume":"126","author":"Weinman","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0670","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.hepres.2005.09.023","article-title":"Hepatitis C as a metabolic disease: implication for the pathogenesis of NASH [J]","volume":"33","author":"Koike","year":"2005","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0675","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/hep.22425","article-title":"The hepatitis C virus-associated dysmetabolic syndrome [J]","volume":"48","author":"Lonardo","year":"2008","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0680","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2036.2007.03538.x","article-title":"Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis [J]","volume":"27","author":"Tsochatzis","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"14","key":"10.1016\/j.metabol.2021.154802_bb0685","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1517\/14656566.2011.597742","article-title":"Metabolic alterations and chronic hepatitis C: treatment strategies [J]","volume":"12","author":"Adinolfi","year":"2011","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"10.1016\/j.metabol.2021.154802_bb0690","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.atherosclerosis.2012.01.051","article-title":"Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis [J]","volume":"221","author":"Adinolfi","year":"2012","journal-title":"Atherosclerosis"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2021.154802_bb0695","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S1590-8658(07)80012-0","article-title":"HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaques [J]","volume":"39","author":"Boddi","year":"2007","journal-title":"Dig Liver Dis"},{"issue":"12","key":"10.1016\/j.metabol.2021.154802_bb0700","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209615","article-title":"Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis [J]","volume":"13","author":"Kawagishi","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.metabol.2021.154802_bb0705","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","article-title":"Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study [J]","volume":"206","author":"Lee","year":"2012","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.metabol.2021.154802_bb0710","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1053\/j.gastro.2011.11.028","article-title":"Hepatitis C virus infects the endothelial cells of the blood-brain barrier [J]","volume":"142","author":"Fletcher","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.metabol.2021.154802_bb0715","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: the role of direct-acting antivirals [J]","volume":"142","author":"Li","year":"2017","journal-title":"Antiviral Res"},{"key":"10.1016\/j.metabol.2021.154802_bb0720","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2147\/DDDT.S254754","article-title":"Danoprevir for the treatment of hepatitis c virus infection: design, development, and place in therapy [J]","volume":"14","author":"Miao","year":"2020","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0725","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5152\/tjg.2018.17330","article-title":"Liver fibrosis [J]","volume":"29","author":"Aydin","year":"2018","journal-title":"Turk J Gastroenterol"},{"issue":"6","key":"10.1016\/j.metabol.2021.154802_bb0730","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1053\/j.gastro.2020.01.043","article-title":"Association between fibrosis stage and outcomes of patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis [J]","volume":"158","author":"Taylor","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.metabol.2021.154802_bb0735","article-title":"Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease [J]","volume":"11","author":"Ballestri","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"7","key":"10.1016\/j.metabol.2021.154802_bb0740","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic fatty liver disease 2020: the state of the disease [J]","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049521001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T04:38:19Z","timestamp":1725165499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049521001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":148,"alternative-id":["S0026049521001025"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154802","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular mechanisms underlying hepatitis C virus infection-related diabetes","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"154802"}}